You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 637 INB-200: Phase I study of gene modified autologous gamma-delta (γδ) T cells in newly diagnosed glioblastoma (GBM) patients receiving maintenance temozolomide (TMZ): immunobiologic correlative data

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
637 INB-200: Phase I study of gene modified autologous gamma-delta (γδ) T cells in newly diagnosed glioblastoma (GBM) patients receiving maintenance temozolomide (TMZ): immunobiologic correlative data

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023262019
Dec 202374012
Jan 20249108
Feb 20244002
Mar 20245207
Apr 20244002
May 20244604
Jun 20243803
Jul 20241401
Aug 20242805
Sep 20245203
Oct 20242406
Nov 20243802
Dec 20242208
Jan 20254208
Feb 2025605
Mar 2025004
Apr 2025008
May 20250013
Jun 2025003
Total8690123